Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 4/2017

01-08-2017 | Editorial

Art and Science of Instrument Development for Stated-Preference Methods

Authors: Ellen M. Janssen, John F. P. Bridges

Published in: The Patient - Patient-Centered Outcomes Research | Issue 4/2017

Login to get access

Excerpt

Ryden et al. [1] contribute to a growing literature on instrument development as it pertains specifically to stated-preference methods. In their article “Discrete choice experiment attribute selection using a multinational interview study: treatment features important to patients with type 2 diabetes mellitus”, they describe how they used both literature reviews and qualitative methods to inform the development of a discrete-choice experiment. Such articles have received more attention as researchers seek to be more transparent on the development of their studies [24]. Guidance by the US Food and Drug Administration has emphasized the need for patient-preference studies to be patient centered, relevant, and understandable with limited bias in the interpretation of choice tasks [5]. These types of study qualities can only be ensured through deliberate instrument development. …
Literature
1.
go back to reference Ryden A, Chen S, Flood E, Romero B, Grandy S. Discrete choice experiment attribute selection using a multinational interview study: treatment features important to patients with type 2 diabetes mellitus. Patient. 2017. doi:10.1007/s40271-017-0225-0. [Epub ahead of print]. Ryden A, Chen S, Flood E, Romero B, Grandy S. Discrete choice experiment attribute selection using a multinational interview study: treatment features important to patients with type 2 diabetes mellitus. Patient. 2017. doi:10.​1007/​s40271-017-0225-0. [Epub ahead of print].
2.
go back to reference Oakes AH, Garmo V, Bone LR, Longo DR, Segal JB, Bridges JFP. Developing a stated-preference instrument to quantitatively assess the barriers and facilitators to the self-management of type 2 diabetes. Patient. 2017. doi:10.1007/s40271-017-0248-6. [Epub ahead of print]. Oakes AH, Garmo V, Bone LR, Longo DR, Segal JB, Bridges JFP. Developing a stated-preference instrument to quantitatively assess the barriers and facilitators to the self-management of type 2 diabetes. Patient. 2017. doi:10.​1007/​s40271-017-0248-6. [Epub ahead of print].
4.
go back to reference O’Hara NN, Roy L, O’Hara LM, Spiegel JM, Lynd LD, FitzGerald JM, et al. Healthcare worker preferences for active tuberculosis case finding programs in South Africa: a best-worst scaling choice experiment. PLoS One. 2015;10(7):e0133304.CrossRef O’Hara NN, Roy L, O’Hara LM, Spiegel JM, Lynd LD, FitzGerald JM, et al. Healthcare worker preferences for active tuberculosis case finding programs in South Africa: a best-worst scaling choice experiment. PLoS One. 2015;10(7):e0133304.CrossRef
6.
go back to reference Vass C, Rigby D, Payne K. The role of qualitative research methods in discrete choice experiments: a systematic review and survey of authors. Med Decis Making. 2017;37(3):298–313.CrossRef Vass C, Rigby D, Payne K. The role of qualitative research methods in discrete choice experiments: a systematic review and survey of authors. Med Decis Making. 2017;37(3):298–313.CrossRef
7.
go back to reference Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health: a checklist. A report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13. doi:10.1016/j.jval.2010.11.013.CrossRefPubMed Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health: a checklist. A report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13. doi:10.​1016/​j.​jval.​2010.​11.​013.CrossRefPubMed
8.
go back to reference Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223.CrossRef Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13. doi:10.​1016/​j.​jval.​2012.​08.​2223.CrossRef
9.
go back to reference Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–15. doi:10.1016/j.jval.2016.04.004.CrossRefPubMed Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–15. doi:10.​1016/​j.​jval.​2016.​04.​004.CrossRefPubMed
10.
go back to reference Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–41. doi:10.1002/hec.1739.CrossRefPubMed Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–41. doi:10.​1002/​hec.​1739.CrossRefPubMed
12.
go back to reference DosReis S, Castillo WC, Ross M, Fitz-Randolph M, Vaughn-Lee A, Butler B. Attribute development using continuous stakeholder engagement to prioritize treatment decisions: a framework for patient-centered research. Value Health. 2016;19(6):758–66. doi:10.1016/j.jval.2016.02.013.CrossRefPubMed DosReis S, Castillo WC, Ross M, Fitz-Randolph M, Vaughn-Lee A, Butler B. Attribute development using continuous stakeholder engagement to prioritize treatment decisions: a framework for patient-centered research. Value Health. 2016;19(6):758–66. doi:10.​1016/​j.​jval.​2016.​02.​013.CrossRefPubMed
15.
go back to reference Aristides M, Weston AR, FitzGerald P, Le Reun C, Maniadakis N. Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment. Value Health. 2004;7(4):442–54.CrossRef Aristides M, Weston AR, FitzGerald P, Le Reun C, Maniadakis N. Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment. Value Health. 2004;7(4):442–54.CrossRef
20.
go back to reference Peay HL, Hollin I, Fischer R, Bridges JFP. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014;36(5):624–37.CrossRef Peay HL, Hollin I, Fischer R, Bridges JFP. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014;36(5):624–37.CrossRef
21.
go back to reference dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF. Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD: a pilot study. Patient. 2014;8(5):423–31. doi:10.1007/s40271-014-0098-4.CrossRef dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF. Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD: a pilot study. Patient. 2014;8(5):423–31. doi:10.​1007/​s40271-014-0098-4.CrossRef
22.
go back to reference Wittenberg E. Instrument development in choice experiments. Commentary on: “Applying a framework for instrument development of a choice experiment to measure treatment preferences in type 2 diabetes”. Patient. 2016;9(5):379–81. doi:10.1007/s40271-016-0186-8.CrossRefPubMed Wittenberg E. Instrument development in choice experiments. Commentary on: “Applying a framework for instrument development of a choice experiment to measure treatment preferences in type 2 diabetes”. Patient. 2016;9(5):379–81. doi:10.​1007/​s40271-016-0186-8.CrossRefPubMed
Metadata
Title
Art and Science of Instrument Development for Stated-Preference Methods
Authors
Ellen M. Janssen
John F. P. Bridges
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 4/2017
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-017-0261-9

Other articles of this Issue 4/2017

The Patient - Patient-Centered Outcomes Research 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.